Why SK Life Science Labs’ AACR 2026 data could put targeted protein degradation back in the oncology spotlight
What Doximity (NYSE: DOCS) CFO resignation means for governance, capital allocation, and investor confidence
Read More Healthcare Industry News Roche to acquire molecular diagnostic solutions firm GenMark Diagnostics Roche has agreed to acquire US-based molecular diagnostic solutions provider GenMark Diagnostics for $24.05 per share or about… byPallavi MadhirajuMarch 16, 2021
